NIH Sees Computerization As Remedy For Paper Flood

Automated grant system could cut months off the proposal process. By 1990, the paper weight could lighten, those grant applications filling the mailrooms at the National Institutes of Health at the rate of 40 or so pages times seven copies times 25,000 proposals a year. The retyping at NIH could ease, too. Probably few grantees are aware that much of the administrative information on grant appli- cations is rekeyed in its travels through the agency. The abstract is retyped twice. To defe

Written byLiane Reif-lehrer
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Automated grant system could cut months off the proposal process.

By 1990, the paper weight could lighten, those grant applications filling the mailrooms at the National Institutes of Health at the rate of 40 or so pages times seven copies times 25,000 proposals a year.

The retyping at NIH could ease, too. Probably few grantees are aware that much of the administrative information on grant appli- cations is rekeyed in its travels through the agency. The abstract is retyped twice.

To defend itself against this juggernaut of paper, NIH is planning to computerize its whole investigator-initiated research (ROI) grant process, from the application to reviewer commentary.

Changes should benefit proposal-writers as well as the agency. The new system could knock a month, possibly three, off the usual nine-month processing time. One of the new system’s features, computer-matching of proposal with Study Section, should make the assignment process more accurate and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies